PROSPECTS OF CLINICAL DIAGNOSIS AND TREATMENT OF ENDOTHELIAL DYSFUNCTION IN PREGNANT WOMEN WITH ARTERIAL HYPERTENSION

Authors

  • I. Ye. Humenna ДВНЗ «Тернопільський державний медичний університет імені І. Я. Горбачевського, МОЗ України

DOI:

https://doi.org/10.11603/24116-4944.2018.1.8804

Keywords:

pregnancy, arterial hypertension, endothelin-1, desquamated endothelial cells, endothelium-dependent vasodilation, endothelial dysfunction, nebivolol hydrochloride.

Abstract

The aim of the study – to evaluate the effect of different antihypertensive therapy programs in pregnant women with chronic arterial hypertension.

Materials and Methods. 64 pregnant women with chronic arterial hypertension on 30–36 weeks of gestation were examined. For the clinical assessment of the pregnant women state there were considered: monitoring of the blood pressure, echocardiography, blood and urine analyses, proteinuria assessment. To evaluate the function of the endothelium, the modified D. Celermajer technique was used; to evaluate the functional state of the fetus cardiotocography (CTG) and the fetal biophysical profile (BPP) were used. Endothelin-1 concentration and the number of desquamated endotheliocytes in the blood serum were studied for the evaluation of biochemical markers of endothelial function.

Results and Discussion. It was found that, in pregnant women with arterial hypertension during the initial stage there is a central and peripheral hemodynamics disorder, and its severity directly correlates with the severity of the endothelial dysfunction and an increased risk of gestational and perinatal complications.

Conclusions. Tight control of arterial hypertension with normalization of arterial pressure due to inclusion of nebivolol hydrochloride (highly selective beta-blocker with vasodilating properties) in the management program allows preventing the progression of endothelial dysfunction and aggravation of hemocirculation disorders, including the mother-placenta-fetus system. This fact ultimately leads to normalization of Manning score (parameters of biophysical profile).

Author Biography

I. Ye. Humenna, ДВНЗ «Тернопільський державний медичний університет імені І. Я. Горбачевського, МОЗ України

 

References

"Hypertension in Pregnancy". (2013). The American College of Obstetricians and Gynecologists, Task Force. http://www.acog.org/Resources-And-Publications/Task-Force-and-Work-Group-Reports/Hypertension-in-Pregnancy

Trends in maternal mortality: 1990 to 2015: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. (2015). Geneva: World Health Organization; 2015.

Dechanet, C., Fort, A., Barbero-Camps, E., Dechaud, H., Richard, S. & Virsolvy, A. (2011). Endothelin-dependent vasoconstriction in human uterine artery : Application to preeclampsia. PLoS ONE, 6 (1), e16540. https://doi.org/10.1371/journal.pone.0016540

Bulavenko, O. V. & Vaskiv, O. V. (2017) Plazmovі kontsentratsіi endotelіnu-1 i natriiuretychnoho C-peptydy u vahіtnykh іz gestatsіinoiu hіpertenzіieiu [Plasma concentrations of endothelin-1 and C-natriuretic peptide of pregnant women with gestational hypertension]. Perynatolohiiya i pediatriia – Perinatology and Pediatrics, 1 (69), 46-50 [in Ukrainian].

Celermajer, D.S., Sorensen, K.E. & Gooch, V.M. (1992). Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 340, 1111-1115.

Pristrom, A.M., Patseev, S.V., Primakov, A.M. & Fomin, O.Yu. (2013). Mesto nebivolola sredy beta-adrenoblokatorov v lechenii miahkoy (umerennoy) arterialnoy gipertenzii u beremennykh [Place of nebivolol among beta-adrenoblockers in the treatment of mild (moderate) arterial hypertension in pregnant women]. Meditsinskie novosti – Medical News, 2, 70-75 [in Russian].

Magee, L,A., von Dadelszen, P., Phil., D., Rey, E., Ross, S, Asztalos, E., … Singer, J. (2015). Less-tight versus tight control of hypertension in pregnancy. N. Engl. J. Med., 372, 407-417. DOI: 10.1056 / NEJMoa1404595

Marushchenko, Yu.L. (2012). Otsinka stanu ploda v zalezhnosti vid metabolichnykh zmin u vahitnykh z preeklampsiieiu [Evaluation of fetal state depending on metabolic changes in preeclamptic pregnant women]. Tavricheskiy mediko-biologicheskiy vestnik – Taurian Medical and Biological Journal, 15, 2, (58), 138-140 [in Ukrainian].

Panova, I.A., Rokotyanskaya, E.A., Kuzmenko, G.N., Kudryashova, A.V., Popova, I.G., Sitova, L.A., … Khlipunova, D.A. (2016). Markery vospalytelnoy reaktsyy i disfunktsyi endoteliya u beremennykh s hypertenzivnymi rasstroystvami razlichnogo geneza [Markers of inflammatory reaction and endothelial dysfunction in pregnant women with hypertensive disorders of various genesis]. Klinicheskaya laboratornaya diagnostika – Clinical Laboratory Diagnostics, 61 (10), 692-696 [in Russian]. DOI 10.18821/0869-2084-2016-61-10

Petrihchev, N.N., Berkovich, O.A. & Vlasov, T.D. (2001). Diagnosticheskaya tsennost opredeleniya deskvamirovannikh endotelialnykh kletok v krovi [The diagnostic value of the definition of desquamated endothelial cells in the blood]. Klinich. lab. Diahnostika. – Clinical Lab. Diagnostics, 1, 50-52 [in Russian].

Published

2018-05-03

How to Cite

Humenna, I. Y. (2018). PROSPECTS OF CLINICAL DIAGNOSIS AND TREATMENT OF ENDOTHELIAL DYSFUNCTION IN PREGNANT WOMEN WITH ARTERIAL HYPERTENSION. Actual Problems of Pediatrics, Obstetrics and Gynecology, (1). https://doi.org/10.11603/24116-4944.2018.1.8804

Issue

Section

OBSTETRICS AND GYNECOLOGY